摘要
目的:探讨环磷腺苷葡胺(MCA)治疗尿素症性心肌病的效果。方法:回顾性分析49例尿毒症心肌病患者的病例资料。结果:尿毒症心肌病在常规治疗基础上辅以环磷腺苷葡胺治疗,MCA可以改善尿毒症心肌病患者左心功能,且疗效优于对照组(P<0.05或P<0.01);MCA治疗在一定时间内改善左室结构且优于对照组,差异有统计学意义(P<0.05或P<0.001)。结论:在常规治疗基础上辅以MCA治疗对尿毒症性心肌病具有较好的治疗效果。
Objective：to discuss the efficacy of Meglumine Adenosine Cyclophosphate in treating uremic car- diomyopathy. Method＇retrospective analysis of 49 cases of uremic cariomypopathy patients data.Results：Meglumine adenosine cyclophosphate （MCA）, with the help of Conventional treatment, can improve left heart function in uremic cardiomyopathy patients .we find MCA has benefit in treating uremic cardiomyopathy compared with control group （P〈0.05 OR P〈0.01）,and it can prevent ventricular remodeling compared with control group（P〈0.05 OR P〈O.O1）.Con- clusion：Regular treatment combined with MCA has favorable treatment efficacy for uremic cariomyopathy.
出处
《安徽卫生职业技术学院学报》
2013年第6期27-28,共2页
Journal of Anhui Health Vocational & Technical College
关键词
尿毒症心肌病
环磷腺苷葡胺
左心功能
左室结构
Uremic cardiomyopathy
Meglumine adenosine cyclophosphate
Left ventricular function
Left ven- tricular structure
